| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2018.02.112 |
| P698 | PubMed publication ID | 29523451 |
| P2093 | author name string | Zheng Xu | |
| Yuan Gao | |||
| Li Xu | |||
| Jing Lv | |||
| Zhujun Shao | |||
| Xiaofang Sun | |||
| Aiyu Zhang | |||
| Bingqing Zhu | |||
| Fenglin Shi | |||
| P2860 | cites work | A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups | Q44128039 |
| Global epidemiology of meningococcal disease. | Q44677055 | ||
| Genetic characteristics of serogroup A meningococci circulating in China, 1956-2005. | Q44741560 | ||
| Molecular characterization of serogroup C Neisseria meningitidis isolated in China. | Q50922863 | ||
| Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide. | Q51834433 | ||
| A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial | Q57588792 | ||
| Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. | Q64901018 | ||
| Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000 | Q74457220 | ||
| Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease | Q78805120 | ||
| Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease | Q83222896 | ||
| Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease | Q84554545 | ||
| The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans | Q84920371 | ||
| NadA, a novel vaccine candidate of Neisseria meningitidis | Q24675323 | ||
| Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms | Q24685491 | ||
| Meningococcal Vaccinations | Q26752993 | ||
| Emerging experience with meningococcal serogroup B protein vaccines | Q30234958 | ||
| Review of meningococcal group B vaccines | Q33646965 | ||
| Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005 | Q33729202 | ||
| Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans | Q33734798 | ||
| Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06. | Q33752108 | ||
| An epidemiological review of changes in meningococcal biology during the last 100 years | Q33850814 | ||
| Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines | Q34320259 | ||
| Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies | Q34529441 | ||
| NadA diversity and carriage in Neisseria meningitidis | Q34761302 | ||
| Sequence Type 4821 Clonal Complex Serogroup B Neisseria meningitidis in China, 1978-2013. | Q35673367 | ||
| Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets | Q35708801 | ||
| Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia. | Q36064003 | ||
| A universal vaccine for serogroup B meningococcus | Q36101910 | ||
| Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 | Q36370598 | ||
| Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined | Q36684761 | ||
| Global epidemiology of invasive meningococcal disease | Q37359946 | ||
| Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. | Q37734624 | ||
| The changing and dynamic epidemiology of meningococcal disease | Q37969481 | ||
| Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review. | Q38118371 | ||
| A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults. | Q38467225 | ||
| Prevalence of meningococcal meningitis in China from 2005 to 2010. | Q39090612 | ||
| Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China | Q40353002 | ||
| Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine | Q41012990 | ||
| Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein | Q41922489 | ||
| Clonal characteristics of invasive Neisseria meningitidis following initiation of an A + C vaccination program in China, 2005-2012. | Q42202574 | ||
| Neisseria meningitidis serogroup W135, China | Q42407752 | ||
| A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults | Q42684461 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Neisseria meningitidis | Q154625 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1983-1989 | |
| P577 | publication date | 2018-03-07 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China. | |
| P478 | volume | 36 |
Search more.